C Partners Holding Gmb H Biogen Inc. Transaction History

C Partners Holding Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$278.5 - $352.75 $98,032 - $124,168	-352 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $130,611 - $170,804	-445 Reduced 55.83%	352 $124,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $40,430 - $48,184	157 Added 24.53%	797 $231,000
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $52,806 - $74,685	-203 Reduced 24.08%	640 $175,000
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $259,340 - $290,480	843	843 $269,000

1,050

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of C Partners Holding Gmb H, based on Form 13F filings with the SEC.

Stay updated on C Partners Holding Gmb H with notifications on news.